TRT on TikTok: separating protocol facts from bro-science

What did @trtsgtmaj2 actually say?

The creator, who calls himself the "TRT sergeant major," describes his personal testosterone protocol: 75 milligrams of testosterone cypionate per week, split across three subcutaneous injections. He frames it around a principle worth examining: "the goal is to be on the lowest dose possible and feel the best." He also fields a question about whether subcutaneous (subQ) injection is a legitimate route, and suggests it gives more injection site options. Then he invites followers to ask what dose they're on, turning the comments into a crowdsourced dosing conversation.

To be clear: he's describing his own protocol, not writing a prescription. But the framing, asking followers "how much testosterone should you be taking per week," nudges toward a kind of community dosing consensus that has no place in clinical medicine. That part deserves scrutiny.

Does the science back this up?

On the low-dose philosophy, he's directionally correct. The clinical goal of TRT is symptom resolution at the lowest effective dose, not chasing a number. That said, what counts as "lowest" is individual, and 75mg per week lands within a reasonable therapeutic range for many patients.

The subcutaneous route has legitimate clinical backing. A 2017 study by Olsson et al. in the Journal of Clinical Endocrinology and Metabolism found that subQ testosterone cypionate produces stable serum testosterone levels comparable to intramuscular administration, with potentially less fluctuation. A 2021 review by Spratt et al. in Andrology confirmed subQ is increasingly used in clinical practice with acceptable tolerability. So his preference for subQ is not just comfort-driven, it's actually supported by pharmacokinetic data.

Splitting doses across three injections per week also has pharmacological logic. More frequent dosing with shorter-acting esters like cypionate reduces peak-to-trough variation in serum testosterone, which some patients report correlates with mood and energy stability, though large-scale randomized trial data on subjective outcomes by injection frequency remain limited.

What did they get wrong (or right)?

Let's give credit where it's due. The low-dose philosophy, the subQ route, and the frequency split are all defensible positions that align with how thoughtful clinicians approach TRT. He's not recommending supraphysiological doses or anabolic stacking. That puts him well above a lot of TRT content on this platform.

What's problematic is the framing of dosing as a group discussion. Asking followers "how much testosterone should you be taking per week" treats a clinical decision like a poll. Testosterone dosing is driven by symptoms, labs, hematocrit, and a provider's assessment of individual risk factors including cardiovascular history. The American Urological Association's 2018 testosterone deficiency guidelines are explicit: dosing should be individualized and monitored. There is no crowdsourced answer to that question.

The claim that he's helping "so many guys and gals get peptides and TRT" also raises questions about what that process actually looks like and whether appropriate clinical gatekeeping is happening, though the video doesn't give enough detail to evaluate that directly.

What should you actually know?

If you're considering TRT, a few things matter more than any single creator's protocol. First, diagnosis comes before dosing. Hypogonadism is defined by both symptoms and consistently low serum testosterone, typically below 300 ng/dL on morning labs, per Endocrine Society guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). Without confirmed low levels, TRT is not indicated regardless of how good someone's protocol sounds.

Second, subQ is a valid route but requires proper technique and rotation. Rotating sites reduces the risk of localized lipohypertrophy, which can affect absorption over time.

Third, 75mg per week is within a commonly used clinical range, but your dose is not his dose. Hematocrit, estradiol conversion, symptom response, and cardiovascular risk factors all influence what a provider should prescribe. Copying someone's protocol from TikTok without labs is not a therapy plan, it's a guess.

Fourth, the Endocrine Society and AUA both recommend monitoring at 3-6 months after initiation, then annually, checking testosterone levels, hematocrit, PSA in men over 40, and symptom burden. No monitoring plan means no safety net.